Clinical Trial Results TV
March 9, 2006: ACS in the Era of Gluttony and Sloth: Considering the Metabolic Syndrome
This video is sponsored by the Duke Clinical Medical Series.

Topics include:
* Case Presentation
* ACS in the Era of Gluttony and Sloth: Considering the Metabolic Syndrome
* NCEP ATP III Criteria for Metabolic Syndrome
* Prevalence of Metabolic Syndrome Components: NHANES III
* Obesity Trends Among U.S. Adults: BRFSS in 1985
* Visceral Adiposity: The Heart of the Problem
* Prevalence of Metabolic Syndrome Components: MIRACL Study
* Metabolic Syndrome and CV Risk After ACS
* Overweight and Obesity in ACS: SYMPHONY Studies
* Adjusted Mortality by BMI: Observations from SYMPHONY Studies

The moderator, Kristin Newby, MD, has indicated that she receives research/grant support
from Bristol-Myers Squibb, Sanofi, Millennium Pharmaceuticals, Inc., Schering-Plough
Research Institute, Novartis and Roche Diagnostics Corporation. Dr. Newby is also a member
of an advisory board for Eli Lilly and a consultant for Proctor and Gamble; she has spoken
at scientific symposia for Aventis, Bristol-Myers Squibb, Sanofi and Millennium
Pharmaceuticals, Inc.

The guest faculty, Darren McGuire, MD, has indicated that he receives research/grant
support from GlaxoSmithKline, Pfizer, and Biosite, Inc. He also receives honoraria from
Takeda and Pfizer.



ACS in the Era of Gluttony and Sloth: Considering the Metabolic Syndrome

Please select your viewing options:

Windows Media: 56k 100k
RealPlayer: 56k 100k
Number Viewing:
Need a media player? Please choose one of the free downloads below:
Get Windows Media PlayerDownload RealPlayer

Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
08-21-2018 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted